CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
PROTEUS is a multicentre, two arm, randomised controlled trial of a medical device to assess the impact of the introduction of EchoGo into the standa...
London, United Kingdom and 19 other locations
is intended to assess the ability of AZD3427 to reduce pulmonary vascular resistance (PVR) after 24 weeks of treatment in participants with heart...
Phase 2
London, United Kingdom and 64 other locations
The purpose is to compare median two-year clinical outcome after OCT guided vs. standard guided revascularization of patients requiring complex bifur...
London, United Kingdom and 37 other locations
Familial Hypercholesterolemia (HeFH) or Premature Coronary Artery Disease (CAD) Who Require Additional Lowering of LDL-C. VERVE-102 Uses Bas...
Phase 1
London, United Kingdom and 2 other locations
The study intends to compare standard ischemic cold static storage (ICSS) of retrieved hearts intended to be transplanted, to non-ischemic h...
Cambridge, United Kingdom and 14 other locations
Evaluation of TAVR using the NAVITOR valve in a Global Investigation.
London, United Kingdom and 37 other locations
Multi-center, prospective, randomized controlled study comparing PCI guided by angiography versus iFR Co-Registration using commercially available Ph...
London, United Kingdom and 82 other locations
with placebo in reducing the risk of the clinical consequences of AKI (MAKE) at 90 days in adult participants with CKD who undergo non-emergent cardiac...
Phase 3
London, United Kingdom and 186 other locations
Hypertrophic Cardiomyopathy (HCM) is an inherited heart condition. Most people who have it are unaware of any problems relating to it. Unfor...
London, United Kingdom
2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart...
London, United Kingdom and 131 other locations
Clinical trials
Research sites
Resources
Legal